NCT01900444View on ClinicalTrials.gov

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

July 11, 2013

Primary Completion Date

March 11, 2014

Study Completion Date

March 11, 2014

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

IMOJEV

0.5 mL, Subcutaneous

Trial Locations (8)

Unknown

Investigational Site 004, Gyeonggi-do

Investigational Site 010, Gyeonggi-do

Investigational Site 001, Seoul

Investigational Site 005, Seoul

Investigational Site 006, Seoul

Investigational Site 008, Seoul

Investigational Site 009, Seoul

Investigational Site 007, Wŏnju

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01900444 - Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea | Biotech Hunter | Biotech Hunter